Monitoring of minimal residual disease (MRD) in chronic myeloid leukemia: recent advances

C Cumbo, L Anelli, G Specchia… - Cancer management and …, 2020 - Taylor & Francis
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm caused by the BCR-ABL1
fusion gene generation as a consequence of the t (9; 22)(q34; q11) rearrangement. The …
被引用次数：45 相关文章

Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances.

C Cumbo, L Anelli, G Specchia… - Cancer Management and …, 2020 - europepmc.org
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm caused by the BCR-ABL1
fusion gene generation as a consequence of the t (9; 22)(q34; q11) rearrangement. The …

Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances

C Cumbo, L Anelli, G Specchia… - Cancer Management and …, 2020 - dovepress.com
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm caused by the BCR-ABL1
fusion gene generation as a consequence of the t (9; 22)(q34; q11) rearrangement. The …

Monitoring of minimal residual disease (Mrd) in chronic myeloid leukemia: Recent advances

C Cumbo, L Anelli, G Specchia… - CANCER MANAGEMENT …, 2020 - ricerca.uniba.it
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm caused by the BCR-ABL1
fusion gene generation as a consequence of the t (9; 22)(q34; q11) rearrangement. The …

Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances.

C Cumbo, L Anelli, G Specchia… - Cancer Management and …, 2020 - go.gale.com
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm caused by the BCR-ABL1
fusion gene generation as a consequence of the t (9; 22)(q34; q11) rearrangement. The …

Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances

C Cumbo, L Anelli, G Specchia… - Cancer management …, 2020 - pubmed.ncbi.nlm.nih.gov
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm caused by the BCR-ABL1
fusion gene generation as a consequence of the t (9; 22)(q34; q11) rearrangement. The …
[HTML] nih.gov

[HTML][HTML] Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances

C Cumbo, L Anelli, G Specchia… - Cancer Management and …, 2020 - ncbi.nlm.nih.gov
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm caused by the BCR-ABL1
fusion gene generation as a consequence of the t (9; 22)(q34; q11) rearrangement. The …